Lyka Labs Limited (LYKALABS) reports a 34% revenue surge and a 136% net profit increase in Q2FY27.
OneSource Specialty Pharma Limited (NSE: ONESOURCE) receives USFDA EIR with VAI classification for its Bengaluru facility, marking successful completion of i.
Biocon Limited (NSE: BIOCON) named among Science Magazine’s Best Employers in Global Biotech and Pharma for 2026, reflecting its strong culture and social re.
Zota Health Care Limited (ZOTA) reports a 54.58% YoY revenue growth and positive EBITDA for Q2FY27, highlighting strong Davaindia sales.
Onesource Specialty Pharma Limited (NSE: ONESOURCE) announces Q2FY27 results with revenue up 37% YoY and EBITDA up 53% YoY.
Biocon Limited (BIOCON) announced that its Pertuzumab biosimilar secured EMA CHMP approval, marking a significant milestone in expanding access to HER2-posit.
Biocon Limited (BIOCON) secures a 10-year supply contract for Pertuzumab in Brazil, marking a significant milestone in advancing HER2-positive breast cancer.
